| 摘要 |
FIELD: medicine; pharmacology. ^ SUBSTANCE: invention refers to medicinal agents and concerns pharmaceutical formulation for nasal absorption containing biologically active acidic polypeptide with isoelectric point 7 and lower; carrier which is water-insoluble or weak-soluble and contains particles of average size 100 mcm and less; and adjuvant for dispersion and consolidation of polypeptide on carrier surface, which is water-insoluble or weak-soluble, where average size of particle contained in specified adjuvant is lower than average size of carrier and is within the range 1 mcm to 20 mcm. ^ EFFECT: improved biological acceptability of biologically active polypeptide. ^ 6 cl, 4 dwg, 11 tbl, 47 ex |
